Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilde Sanson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
European Journal of Translational Myology|September 17, 2021
A revised model for mitochondrial dysfunction in Duchenne muscular dystrophyAi Vu Hong, Mathilde Sanson, Isabelle Richard, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 26, 2021
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophyFatima Amor, Ai Vu Hong, Guillaume Corre, et al.
Scientific Reports|March 29, 2024
Author Correction: miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophyMathilde Sanson, Ai Vu Hong, Emmanuelle Massourides, et al.
Scientific Reports|June 6, 2020
miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophyMathilde Sanson, Ai Vu Hong, Emmanuelle Massourides, et al.
The Journal of Clinical Investigation|September 13, 2022
Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defectHaiyan Zhou, Ying Hong, Mariacristina Scoto, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
European Journal of Translational Myology|September 17, 2021
A revised model for mitochondrial dysfunction in Duchenne muscular dystrophyAi Vu Hong, Mathilde Sanson, Isabelle Richard, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 26, 2021
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophyFatima Amor, Ai Vu Hong, Guillaume Corre, et al.
Scientific Reports|March 29, 2024
Author Correction: miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophyMathilde Sanson, Ai Vu Hong, Emmanuelle Massourides, et al.
Scientific Reports|June 6, 2020
miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophyMathilde Sanson, Ai Vu Hong, Emmanuelle Massourides, et al.
The Journal of Clinical Investigation|September 13, 2022
Microvasculopathy in spinal muscular atrophy is driven by a reversible autonomous endothelial cell defectHaiyan Zhou, Ying Hong, Mariacristina Scoto, et al.
Pageof 1